A United Kingdom government probe into whether GlaxoSmithKline, AstraZeneca Plc, and Indianapolis-based Eli Lilly & Co. bribed the administration of former Iraqi dictator Saddam Hussein may expand to other companies, the Serious Fraud Office said, according to a
report by Bloomberg.
No comments:
Post a Comment